MedTrace Logo

Nurse-Led Transfer Program With Family Involvement to Reduce ICU Patient Anxiety

NCT06979414 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-05-19

No results posted yet for this study

Summary

This study aims to evaluate whether including a patient's family member during transfer from the intensive care unit (ICU) to the general ward can help reduce anxiety in patients who have undergone cardiovascular surgery. The research is being conducted in a cardiovascular ICU in Turkey. Patients in the intervention group are accompanied by a close relative during the transfer process. Their anxiety levels and vital signs are measured before and after the transfer and compared to those of patients transferred without a relative.

Conditions

  • Transfer Anxiety
  • Intensive Care Unit Discharge
  • Cardiac Surgery Recovery
  • Postoperative Anxiety
  • Critical Care Transition

Interventions

BEHAVIORAL

Nurse-led Transfer Programme with Family Involvement

This behavioral intervention was structured in three phases: (1) Pre-transfer preparation, where the patient's primary caregiver visited the ICU for emotional support following verbal instruction and infection control measures; (2) Accompanied transfer to the general ward, led by an ICU nurse, with the caregiver present to provide emotional reassurance; (3) Post-transfer monitoring, where the patient's vital signs and anxiety levels were reassessed within 30-60 minutes of arrival. The goal of the intervention was to reduce ICU transfer-related anxiety through nurse-led, family-involved emotional support.

Sponsors & Collaborators

  • Yakup Akyüz

    lead OTHER

Principal Investigators

  • yakup akyüz, research assistant · istanbul university faculty of nursing department of surgical diseases nursing

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-10-30
Completion
2025-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06979414 on ClinicalTrials.gov